Search - tctmd.com

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Prolonged Bivalirudin Infusion is Associated with Enhanced ST Segment Resolution Following Primary Percutaneous Coronary Intervention

Presenter: Bernardo Cortese, Ugo Limbruno, Sara De Matteis, Livia Diehl, Antonino Pit?

January 03, 2012

Presentation TCT 2012

In hospital and 30 day outcomes in all-comer percutaneous coronary intervention with bivalirudin: Initial report of the prospective EUROVISION Registry. Hamon M, Nienaber C,...

Presenter: Martial Hamon

January 03, 2012

Advertisement

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

Statin Reloading Improves Clinical Outcomes in Stable PCI Patients

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

EXOME: New Genetic Sequencing Zeroes in on Clopidogrel Response Variants

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Better Clopidogrel Response Seen with Increased Smoking Levels

Anemia Inhibits Platelet Response to Clopidogrel in PCI Patients

TCTMD’s Top 10 Most Popular News Stories From 2011

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Prolonged Bivalirudin Infusion is Associated with Enhanced ST Segment Resolution Following Primary Percutaneous Coronary Intervention

In hospital and 30 day outcomes in all-comer percutaneous coronary intervention with bivalirudin: Initial report of the prospective EUROVISION Registry. Hamon M, Nienaber C,...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content